Загрузка...
The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice
Peroxisome Proliferator Activated Receptor (PPAR)-α is a key regulator of lipid metabolism and recent studies reveal it also regulates inflammation in several different disease models. Gemfibrozil, an agonist of PPAR-α, is a FDA approved drug for hyperlipidemia and has been shown to inhibit clinical...
Сохранить в:
| Опубликовано в: : | Exp Neurol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5518476/ https://ncbi.nlm.nih.gov/pubmed/21963672 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2011.09.023 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|